Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.345
-0.195 (-5.51%)
At close: Sep 24, 2026, 4:00 PM EDT
3.350
+0.005 (0.15%)
After-hours: Sep 24, 2026, 4:10 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $197.67 million as of September 24, 2026. Its market cap has increased by 43.11% in one year.
Market Cap
197.67M
Enterprise Value
38.57M
1-Year Change
43.11%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $197.67M, an increase of 14.16%. That is a compound annual growth rate of 1.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 197.67M | -30.79% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 228.96M |
| Protalix BioTherapeutics | 228.82M |
| Cue Biopharma | 224.47M |
| Alector | 224.43M |
| Compass Therapeutics | 223.31M |
| NervGen Pharma | 222.03M |
| ALX Oncology Holdings | 221.24M |
| Adagene | 216.87M |